Characterising the background incidence rates of adverse events of special interest for covid-19 vaccines in eight countries: multinational network cohort study
Objective To quantify the background incidence rates of 15 prespecified adverse events of
special interest (AESIs) associated with covid-19 vaccines. Design Multinational network …
special interest (AESIs) associated with covid-19 vaccines. Design Multinational network …
[HTML][HTML] Contextualising adverse events of special interest to characterise the baseline incidence rates in 24 million patients with COVID-19 across 26 databases: a …
Background Adverse events of special interest (AESIs) were pre-specified to be monitored
for the COVID-19 vaccines. Some AESIs are not only associated with the vaccines, but with …
for the COVID-19 vaccines. Some AESIs are not only associated with the vaccines, but with …
Safety of hydroxychloroquine, alone and in combination with azithromycin, in light of rapid wide-spread use for COVID-19: a multinational, network cohort and self …
Background Hydroxychloroquine has recently received Emergency Use Authorization by the
FDA and is currently prescribed in combination with azithromycin for COVID-19 pneumonia. …
FDA and is currently prescribed in combination with azithromycin for COVID-19 pneumonia. …
[HTML][HTML] Risk of hydroxychloroquine alone and in combination with azithromycin in the treatment of rheumatoid arthritis: a multinational, retrospective study
Background Hydroxychloroquine, a drug commonly used in the treatment of rheumatoid
arthritis, has received much negative publicity for adverse events associated with its …
arthritis, has received much negative publicity for adverse events associated with its …
Azithromycin and levofloxacin use and increased risk of cardiac arrhythmia and death
PURPOSE Azithromycin use has been associated with increased risk of death among
patients at high baseline risk, but not for younger and middle-aged adults. The Food and Drug …
patients at high baseline risk, but not for younger and middle-aged adults. The Food and Drug …
Comparative effectiveness of famotidine in hospitalized COVID-19 patients
A Shoaibi, SP Fortin, R Weinstein… - Official journal of the …, 2021 - journals.lww.com
METHODS: We constructed a retrospective cohort study using data from COVID-19 Premier
Hospital electronic health records. The study population was COVID-19 hospitalized …
Hospital electronic health records. The study population was COVID-19 hospitalized …
[HTML][HTML] A cost effectiveness analysis of salt reduction policies to reduce coronary heart disease in four Eastern Mediterranean countries
Background Coronary Heart Disease (CHD) is rising in middle income countries. Population
based strategies to reduce specific CHD risk factors have an important role to play in …
based strategies to reduce specific CHD risk factors have an important role to play in …
[HTML][HTML] Phenotype algorithms for the identification and characterization of vaccine-induced thrombotic thrombocytopenia in real world data: a multinational network …
Introduction Vaccine-induced thrombotic thrombocytopenia (VITT) has been identified as a
rare but serious adverse event associated with coronavirus disease 2019 (COVID-19) …
rare but serious adverse event associated with coronavirus disease 2019 (COVID-19) …
[HTML][HTML] Deep phenotyping of 34,128 adult patients hospitalised with COVID-19 in an international network study
Comorbid conditions appear to be common among individuals hospitalised with coronavirus
disease 2019 (COVID-19) but estimates of prevalence vary and little is known about the …
disease 2019 (COVID-19) but estimates of prevalence vary and little is known about the …
[HTML][HTML] Seek COVER: using a disease proxy to rapidly develop and validate a personalized risk calculator for COVID-19 outcomes in an international network
Background We investigated whether we could use influenza data to develop prediction
models for COVID-19 to increase the speed at which prediction models can reliably be …
models for COVID-19 to increase the speed at which prediction models can reliably be …
